Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Operating activities:
Net loss	$ (13,467)	$ (10,773)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	1,102	1,162
Share-based compensation	3,843	2,484
Changes in operating assets and liabilities:
Accounts receivable	1,696	(1,083)
Accounts receivable pledged as collateral	0	3,006
Inventories	(154)	738
Accounts payable and accrued liabilities	967	(4,657)
Accrued payroll and employee compensation	(111)	(113)
Other assets and liabilities, net	(28)	1,184
Net cash used in operating activities	(6,152)	(8,052)
Investing activities:
Purchase of fixed assets	(485)	(213)
Purchase of intangible assets	0	(150)
Net cash used in investing activities	(485)	(363)
Financing activities:
Proceeds from issuance of common stock, net of issuance costs	6,579	19,218
Payment for restricted stock units tax liability on net settlement	(814)	0
Proceeds from exercise of outstanding warrants	138	0
Proceeds from exercise of stock options and ESPP purchases	506	20
Proceeds from borrowings	3,500	0
Repayment of accounts receivable pledged as collateral, net	0	(2,329)
Repayment of principal on long-term debt	0	(693)
Net cash provided by (used in) financing activities	9,909	16,216
Effect of exchange rate changes on cash	(10)	18
Net decrease in cash and cash equivalents	3,262	7,819
Cash and cash equivalents, beginning of period	10,168	8,852
Cash and cash equivalents, end of period	13,430	16,671
Non-cash activities — Equity award fair value adjustment to liability	$ (197)	$ 0